#BEGIN_DRUGCARD DB07650

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C11H22O2

# Chemical_IUPAC_Name:
decyl formate

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:24:31 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
DECYL FORMATE

# HET_ID:
DFD

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C11H22O2/c1-2-3-4-5-6-7-8-9-10-13-11-12/h11H,2-10H2,1H3

# InChI_Key:
InChIKey=BCLJZFLDSCTULJ-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
7656

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
186.2912

# Molecular_Weight_Mono:
186.161979948

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
4.86

# Predicted_LogS:
-4.3

# Predicted_Water_Solubility:
9.57e-03 g/l

# Primary_Accession_No:
DB07650

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
79541

# PubChem_Substance_ID:
99444121

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCCCCCCCOC=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:25:53 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
BX842573

# Drug_Target_1_GenBank_ID_Protein:
38490203

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
fabH

# Drug_Target_1_Gene_Sequence:
>1008 bp
TCAACCCTTCGGCATTCGCACCACCTGGGCGGCATAGCTCAGACCGGCGCCGTAGCCGAT
CAACAGGGCCAGATCGCCGGGCTTGGCCGCGCCGGTCGTCAGTAATTCGGCCATCGCGAG
CGGAATGGAGGCCGCCGAGGTGTTTCCGGTGTGCTCGATATCGTTGGCGACCACCGCGTC
GGGCCGCAACTGCAGGTTCTTGACCAGCAGCTCGTTGATGCGGCTATTGGCCTGATGAGG
GACGAACACGTCTATCTGGTCGGGTCGCACCCCGGCGGCGTCCATCGCGCGCCGACCGAC
GTCGCCCATTTTGAACGCTGCCCAACGGAAGACCGCGGGACCTTCGAGCCGCACAAACGG
GCGTGGGCCGCTGGGATTCTGGGCGAAAGTGATCCAGTCGATGTCCTGCCGTATGGCATC
GGCCTGTTCGCCGTCGCTACCCGCCACGGTTGGTCCAATGCCTTGAAACGGTGTCTCGCC
CACCACCACTGCGGCCGCGCCGTCGGCGAAGATGAAGCAGTTGCCGCGGTCGTACATGTC
TATCGTGGGGGACAGTTTTTCCGTGCCGACCACCAGCATCGTGGCCGCACCTCCGCCCCG
GATCATGTCGGCCGCTGCGCCAAGCGCATATCCGAATCCGGCGCACCCCGCCGAAAGATC
GAACCCGAGTATGCCCTTGGCGCCCAGCGACGCCGCGACCATTGGGGCGGCCGGCGGGGT
TTGCAGGAAATGGGTGTTGGTGGTGACGATCACGCCATCGATGTCGGCCGCCGACAGGCC
GGCGTTCGACAGTGCCCGTCGACAGGCCTCAGTCGCCATGGAAGCCGCCGACTCGTCGTC
GGCGGCGAATCGGCGGGTCTTGATGCCGGTTCGGGTGTAGATCCACTCGTCGGACGAGTC
GATGTGCTGGCATATCTCGTCGTTGGTGACCACGCGTTCGGGCCGGTACGCCCCGACACT
GAGCAGCCCGACGCTCCTGGCGCCGCTGGTCGTGGCGATCTCCGTCAT

# Drug_Target_1_General_Function:
Lipid transport and metabolism

# Drug_Target_1_General_References:
10840036	Choi KH, Kremer L, Besra GS, Rock CO: Identification and substrate specificity of beta -ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. J Biol Chem. 2000 Sep 8;275(36):28201-7.
11278743	Scarsdale JN, Kazanina G, He X, Reynolds KA, Wright HT: Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III. J Biol Chem. 2001 Jun 8;276(23):20516-22. Epub 2001 Mar 8.
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3138

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34873

# Drug_Target_1_Name:
3-oxoacyl-[acyl-carrier-protein] synthase 3

# Drug_Target_1_Number_of_Residues:
335

# Drug_Target_1_PDB_ID:
1HZP

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF08541	ACP_syn_III_C
PF08545	ACP_syn_III

# Drug_Target_1_Protein_Sequence:
>3-oxoacyl-[acyl-carrier-protein] synthase 3
MTEIATTSGARSVGLLSVGAYRPERVVTNDEICQHIDSSDEWIYTRTGIKTRRFAADDES
AASMATEACRRALSNAGLSAADIDGVIVTTNTHFLQTPPAAPMVAASLGAKGILGFDLSA
GCAGFGYALGAAADMIRGGGAATMLVVGTEKLSPTIDMYDRGNCFIFADGAAAVVVGETP
FQGIGPTVAGSDGEQADAIRQDIDWITFAQNPSGPRPFVRLEGPAVFRWAAFKMGDVGRR
AMDAAGVRPDQIDVFVPHQANSRINELLVKNLQLRPDAVVANDIEHTGNTSAASIPLAMA
ELLTTGAAKPGDLALLIGYGAGLSYAAQVVRMPKG

# Drug_Target_1_Reaction:
an acyl-[acyl-carrier-protein] + malonyl-[acyl-carrier-protein] = a 3-oxoacyl-[acyl-carrier-protein] + CO2 + [acyl-carrier-protein]

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Catalyzes the first condensation reaction which initiates fatty acid synthesis and may therefore play a role in governing the total rate of fatty acid production. Possesses both acetoacetyl-ACP synthase and acetyl transacylase activities. Has some substrate specificity for long chain acyl-CoA such as myristoyl-CoA. Does not use acyl-CoA as primer. Its substrate specificity determines the biosynthesis of mycolic acid fatty acid chain, which is characteristic of mycobacterial cell wall

# Drug_Target_1_SwissProt_ID:
P0A574

# Drug_Target_1_SwissProt_Name:
FABH_MYCTU

# Drug_Target_1_Synonyms:
3-oxoacyl- [acyl-carrier-protein] synthase III
Beta-ketoacyl-ACP synthase III
EC 2.3.1.41
KAS III
MtFabH

# Drug_Target_1_Theoretical_pI:
4.77

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB07650
